SCHEMBL3950485

SCHEMBL3950485

C=C([Si](C)(C)Cl)[Si](C)(C)Cl

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6520497 0.75
SCHEMBL6521974 0.67
SCHEMBL7913331 0.65
SCHEMBL1617647 0.64
SCHEMBL3699141 0.64
SCHEMBL2686699 0.61
SCHEMBL854551 0.61
SCHEMBL8979243 0.61
Methyl Alcohol SCHEMBL4039315 0.61
Methyl Alcohol SCHEMBL11796003 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9441009-B2 Co-modified organopolysiloxane, and powder treatment agent and powder composition comprising the same DOW CORNING TORAY CO., LTD. (JP) 2016-09-13 US disclosed
US-20150239924-A1 NOVEL CO-MODIFIED ORGANOPOLYSILOXANE, AND POWDER TREATMENT AGENT AND POWDER COMPOSITION COMPRISING THE SAME DOW CORNING TORAY CO., LTD. (JP) 2015-08-27 US disclosed
EP-2905300-A1 NOVEL CO-MODIFIED ORGANOPOLYSILOXANE, POWDER PROCESSING AGENT COMPRISING SAME, AND POWDER COMPOSITION Dow Corning Toray Co., Ltd. (JP) 2015-08-12 EP disclosed
US-7556860-B2 Laminate and method of forming the same, insulating film, and semiconductor device JSR CORPORATION (JP) 2009-07-07 US disclosed
US-20060216531-A1 Laminate and method of forming the same, insulating film, and semiconductor device JSR CORPORATION (JP) 2006-09-28 US disclosed
EP-1679184-A1 LAMINATE AND METHOD FOR FORMATION THEREOF, INSULATING FILM, SEMICONDUCTOR DEVICE, AND COMPOSITION FOR FORMING FILM JSR Corporation (JP) 2006-07-12 EP disclosed
EP-0711290-A1 METHYLGUANIDINE DERIVATIVES, METHODS FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAID DERIVATIVES SANOFI (FR) 1996-05-15 EP disclosed
WO-1995004052-A1 METHYLGUANIDINE DERIVATIVES, METHODS FOR PREPARING SAME AND COMPOSITIONS CONTAINING SAID DERIVATIVES SANOFI (FR) 1995-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239924-A1 NOVEL CO-MODIFIED ORGANOPOLYSILOXANE, AND POWDER TREATMENT AGENT AND POWDER COMPOSITION COMPRISING THE SAME DDOST, IDUA, RPN1 ALDH1A1 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.